Coverart for item
The Resource Biosurveillance & bioWatch generation-3 acquisition, edited by Wyatt E. Fletcher

Biosurveillance & bioWatch generation-3 acquisition, edited by Wyatt E. Fletcher

Label
Biosurveillance & bioWatch generation-3 acquisition
Title
Biosurveillance & bioWatch generation-3 acquisition
Statement of responsibility
edited by Wyatt E. Fletcher
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
N$T
Dewey number
363.3253630973
Index
index present
LC call number
UG447.8
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
Fletcher, Wyatt E
Series statement
Defense, security and strategy
http://library.link/vocab/subjectName
  • BioWatch Program (U.S.)
  • Biological warfare
  • Bioterrorism
  • BioWatch Program (U.S.)
  • BUSINESS & ECONOMICS
  • SOCIAL SCIENCE
  • Biological warfare
  • Bioterrorism
  • United States
Label
Biosurveillance & bioWatch generation-3 acquisition, edited by Wyatt E. Fletcher
Instantiates
Publication
Distribution
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • BIOSURVEILLANCE AND BIOWATCH GENERATION-3 ACQUISITION; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Biosurveillance: DHS Should Reevaluate Mission Need and Alternatives before Proceeding with BioWatch Generation-3 Acquisition(; Why GAO Did This Study; What GAO Recommends; What GAO Found; Abbreviations; Background; BioWatch and the Biodefense Enterprise; BioWatch Past and Present; BioWatch in Action; Gen-3 Development and Challenges; DHS's Four-Phase Acquisition Life-cycle Framework
  • DHS Did Not Fully Develop Critical Information for Initial Investment Decision MakingDHS Did Not Use Acquisition Life-cycle Framework Processes to Identify a Justified Mission Need; DHS Did Not Use Acquisition Life-cycle Processes to Analyze Alternatives Based on Cost, Schedule, and Risk to Identify an Optimal Solution; DHS Did Not Develop Complete and Reliable Performance, Schedule, and Cost Information before Approving the Gen-3 Acquisition; BioWatch Must Demonstrate System Performance and Receive Approval before; Full Deployment, Estimated for 2022; Conclusions
  • Recommendations for Executive ActionAgency Comments and Our Evaluation; Appendix I. Limitations of Gen-3 Acquisition Documents and; Processes at ADE-2A; Appendix II. BioWatch Gen-3 Characterization Test Events and Candidate Technology Performance against Key Performance Parameters; End Notes; Chapter 2: Statement of Gus Bilirakis, Chairman, Subcommittee on Emergency Preparedness, Response, and Communications. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(
  • Chapter 3: Statement of Dan Lungren, Chairman, Subcommittee on Cybersecurity, Infrastructure Protection, and Security Technologies. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(Chapter 4: Testimony of Alexander G. Garza, Assistant Secretary for Health Affairs and Chief Medical Officer, U.S. Department of Homeland Security. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(; End Note
  • Chapter 5: Testimony of Rafael Borras, Under Secretary for Management, U.S. Department of Homeland Security. Hearing on ''BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?''(BioWatch Gen-3 Investment and Acquisition Oversight Activities; Conclusion; Chapter 6: Testimony of Frances Phillips, Deputy Secretary for Public Health Services, Maryland Department of Health and Mental Hygiene. Hearing on ''BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?''*; Index
Control code
876861694
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781624172205
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)876861694
Label
Biosurveillance & bioWatch generation-3 acquisition, edited by Wyatt E. Fletcher
Publication
Distribution
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • BIOSURVEILLANCE AND BIOWATCH GENERATION-3 ACQUISITION; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Biosurveillance: DHS Should Reevaluate Mission Need and Alternatives before Proceeding with BioWatch Generation-3 Acquisition(; Why GAO Did This Study; What GAO Recommends; What GAO Found; Abbreviations; Background; BioWatch and the Biodefense Enterprise; BioWatch Past and Present; BioWatch in Action; Gen-3 Development and Challenges; DHS's Four-Phase Acquisition Life-cycle Framework
  • DHS Did Not Fully Develop Critical Information for Initial Investment Decision MakingDHS Did Not Use Acquisition Life-cycle Framework Processes to Identify a Justified Mission Need; DHS Did Not Use Acquisition Life-cycle Processes to Analyze Alternatives Based on Cost, Schedule, and Risk to Identify an Optimal Solution; DHS Did Not Develop Complete and Reliable Performance, Schedule, and Cost Information before Approving the Gen-3 Acquisition; BioWatch Must Demonstrate System Performance and Receive Approval before; Full Deployment, Estimated for 2022; Conclusions
  • Recommendations for Executive ActionAgency Comments and Our Evaluation; Appendix I. Limitations of Gen-3 Acquisition Documents and; Processes at ADE-2A; Appendix II. BioWatch Gen-3 Characterization Test Events and Candidate Technology Performance against Key Performance Parameters; End Notes; Chapter 2: Statement of Gus Bilirakis, Chairman, Subcommittee on Emergency Preparedness, Response, and Communications. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(
  • Chapter 3: Statement of Dan Lungren, Chairman, Subcommittee on Cybersecurity, Infrastructure Protection, and Security Technologies. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(Chapter 4: Testimony of Alexander G. Garza, Assistant Secretary for Health Affairs and Chief Medical Officer, U.S. Department of Homeland Security. Hearing on "BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?"(; End Note
  • Chapter 5: Testimony of Rafael Borras, Under Secretary for Management, U.S. Department of Homeland Security. Hearing on ''BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?''(BioWatch Gen-3 Investment and Acquisition Oversight Activities; Conclusion; Chapter 6: Testimony of Frances Phillips, Deputy Secretary for Public Health Services, Maryland Department of Health and Mental Hygiene. Hearing on ''BioWatch Present and Future: Meeting Mission Needs for Effective Biosurveillance?''*; Index
Control code
876861694
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781624172205
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)876861694

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...